PubRank

James M Musser

Author PubWeight™ 258.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007 8.99
2 Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005 5.18
3 Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci U S A 2002 5.07
4 Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci U S A 2002 4.85
5 spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol 2004 4.80
6 Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A 2008 4.38
7 Genome-wide analysis of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis complex organisms: resolution of genetic relationships among closely related microbial strains. Genetics 2002 4.11
8 Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis 2005 3.89
9 Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci U S A 2002 3.83
10 Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog 2006 3.68
11 Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci U S A 2006 3.33
12 Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J Infect Dis 2005 3.32
13 Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci U S A 2005 2.84
14 Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A 2014 2.63
15 Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 2012 2.62
16 Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae. Proc Natl Acad Sci U S A 2014 2.56
17 Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci U S A 2003 2.54
18 Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc Natl Acad Sci U S A 2005 2.45
19 Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J Infect Dis 2005 2.45
20 Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci U S A 2010 2.43
21 Molecular correlates of host specialization in Staphylococcus aureus. PLoS One 2007 2.41
22 Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci U S A 2004 2.32
23 Progress toward characterization of the group A Streptococcus metagenome: complete genome sequence of a macrolide-resistant serotype M6 strain. J Infect Dis 2004 2.29
24 The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence. Trends Microbiol 2002 2.27
25 Contribution of exogenous genetic elements to the group A Streptococcus metagenome. PLoS One 2007 2.22
26 In vitro serial passage of Staphylococcus aureus: changes in physiology, virulence factor production, and agr nucleotide sequence. J Bacteriol 2002 2.19
27 Staphylococcus aureus aconitase inactivation unexpectedly inhibits post-exponential-phase growth and enhances stationary-phase survival. Infect Immun 2002 2.10
28 Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol 2005 2.05
29 A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus. Proc Natl Acad Sci U S A 2008 2.02
30 Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol Microbiol 2007 2.01
31 Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A 2003 1.99
32 Characterization of the Manila family of Mycobacterium tuberculosis. J Clin Microbiol 2003 1.89
33 Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One 2007 1.89
34 Rapidly progressive, fatal, inhalation anthrax-like infection in a human: case report, pathogen genome sequencing, pathology, and coordinated response. Arch Pathol Lab Med 2011 1.83
35 Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data. J Biol Chem 2003 1.81
36 Identification and characterization of a novel heme-associated cell surface protein made by Streptococcus pyogenes. Infect Immun 2002 1.79
37 Rgg influences the expression of multiple regulatory loci to coregulate virulence factor expression in Streptococcus pyogenes. Infect Immun 2002 1.78
38 Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci U S A 2011 1.70
39 rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J Clin Microbiol 2006 1.68
40 Identification and characterization of HtsA, a second heme-binding protein made by Streptococcus pyogenes. Infect Immun 2003 1.68
41 Association between interleukin-8 gene alleles and human susceptibility to tuberculosis disease. J Infect Dis 2003 1.68
42 An apoptosis-differentiation program in human polymorphonuclear leukocytes facilitates resolution of inflammation. J Leukoc Biol 2003 1.66
43 Correlation of acetate catabolism and growth yield in Staphylococcus aureus: implications for host-pathogen interactions. Infect Immun 2003 1.66
44 Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun 2010 1.62
45 CovS simultaneously activates and inhibits the CovR-mediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes. Infect Immun 2009 1.62
46 Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol 2008 1.62
47 Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity. J Bacteriol 2003 1.59
48 Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315. Infect Immun 2003 1.57
49 Molecular pathogenesis of necrotizing fasciitis. Annu Rev Pathol 2010 1.56
50 The agr radiation: an early event in the evolution of staphylococci. J Bacteriol 2005 1.55
51 A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect Immun 2008 1.54
52 Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection. Am J Pathol 2006 1.53
53 Group A Streptococcus gene expression in humans and cynomolgus macaques with acute pharyngitis. Infect Immun 2003 1.53
54 Genome diversification in Staphylococcus aureus: Molecular evolution of a highly variable chromosomal region encoding the Staphylococcal exotoxin-like family of proteins. Infect Immun 2003 1.53
55 M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J Clin Microbiol 2002 1.51
56 Rgg coordinates virulence factor synthesis and metabolism in Streptococcus pyogenes. J Bacteriol 2003 1.50
57 Genome sequence of a Lancefield group C Streptococcus zooepidemicus strain causing epidemic nephritis: new information about an old disease. PLoS One 2008 1.49
58 Structure and distribution of an unusual chimeric genetic element encoding macrolide resistance in phylogenetically diverse clones of group A Streptococcus. J Infect Dis 2003 1.49
59 Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci U S A 2010 1.47
60 Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells. Proc Natl Acad Sci U S A 2002 1.42
61 Maltodextrin utilization plays a key role in the ability of group A Streptococcus to colonize the oropharynx. Infect Immun 2006 1.42
62 New understanding of the group A Streptococcus pathogenesis cycle. Trends Microbiol 2007 1.41
63 Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins. J Infect Dis 2003 1.39
64 Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations. Proc Natl Acad Sci U S A 2011 1.39
65 The role of complex carbohydrate catabolism in the pathogenesis of invasive streptococci. Trends Microbiol 2008 1.38
66 Growth characteristics of and virulence factor production by group A Streptococcus during cultivation in human saliva. Infect Immun 2005 1.37
67 Evidence for recombination in Mycobacterium tuberculosis. J Bacteriol 2006 1.37
68 Natural disruption of two regulatory networks in serotype M3 group A Streptococcus isolates contributes to the virulence factor profile of this hypervirulent serotype. Infect Immun 2014 1.36
69 Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 2004 1.35
70 Isoniazid activation defects in recombinant Mycobacterium tuberculosis catalase-peroxidase (KatG) mutants evident in InhA inhibitor production. Antimicrob Agents Chemother 2003 1.33
71 Tuberculosis disparity between US-born blacks and whites, Houston, Texas, USA. Emerg Infect Dis 2009 1.33
72 Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci U S A 2005 1.33
73 Genome sequence survey identifies unique sequences and key virulence genes with unusual rates of amino Acid substitution in bovine Staphylococcus aureus. Infect Immun 2002 1.33
74 Complete nucleotide sequence analysis of plasmids in strains of Staphylococcus aureus clone USA300 reveals a high level of identity among isolates with closely related core genome sequences. J Clin Microbiol 2010 1.32
75 Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group A Streptococcus. Am J Pathol 2012 1.32
76 Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010. Emerg Infect Dis 2011 1.32
77 The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol 2008 1.30
78 Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease. Proc Natl Acad Sci U S A 2005 1.30
79 A molecular trigger for intercontinental epidemics of group A Streptococcus. J Clin Invest 2015 1.29
80 Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice. J Clin Invest 2011 1.28
81 Human disease isolates of serotype m4 and m22 group a streptococcus lack genes required for hyaluronic acid capsule biosynthesis. MBio 2012 1.27
82 Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis. J Clin Microbiol 2005 1.26
83 Phylogeography of the spring and fall waves of the H1N1/09 pandemic influenza virus in the United States. J Virol 2010 1.23
84 Virulence of serotype M3 Group A Streptococcus strains in wax worms (Galleria mellonella larvae). Virulence 2011 1.23
85 Expression microarray and mouse virulence analysis of four conserved two-component gene regulatory systems in group a streptococcus. Infect Immun 2006 1.22
86 Secreted bacterial phospholipase A2 enzymes: better living through phospholipolysis. Trends Microbiol 2006 1.22
87 Extensive adaptive changes occur in the transcriptome of Streptococcus agalactiae (group B streptococcus) in response to incubation with human blood. PLoS One 2008 1.19
88 Molecular analysis of group A Streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah. J Clin Microbiol 2002 1.19
89 Sequence variation in group A Streptococcus pili and association of pilus backbone types with lancefield T serotypes. J Infect Dis 2008 1.18
90 Engagement of the pathogen survival response used by group A Streptococcus to avert destruction by innate host defense. J Immunol 2004 1.17
91 Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens. PLoS One 2009 1.17
92 Comparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population. Clin Vaccine Immunol 2006 1.16
93 Opsonophagocytosis-inhibiting mac protein of group a streptococcus: identification and characteristics of two genetic complexes. Infect Immun 2002 1.16
94 From transcription to activation: how group A streptococcus, the flesh-eating pathogen, regulates SpeB cysteine protease production. Mol Microbiol 2011 1.16
95 Insight of host immune evasion mediated by two variants of group a Streptococcus Mac protein. J Biol Chem 2004 1.16
96 Identification and characterization of an antigen I/II family protein produced by group A Streptococcus. Infect Immun 2006 1.14
97 Postgenomic analysis of four novel antigens of group a streptococcus: growth phase-dependent gene transcription and human serologic response. J Bacteriol 2002 1.14
98 Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case. Mol Cell Proteomics 2012 1.13
99 A genomic day in the life of a clinical microbiology laboratory. J Clin Microbiol 2013 1.13
100 Genomic analysis of emm59 group A Streptococcus invasive strains, United States. Emerg Infect Dis 2012 1.10
101 A combination of independent transcriptional regulators shapes bacterial virulence gene expression during infection. PLoS Pathog 2010 1.10
102 Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2. Proc Natl Acad Sci U S A 2006 1.09
103 High-throughput RNA sequencing of a formalin-fixed, paraffin-embedded autopsy lung tissue sample from the 1918 influenza pandemic. J Pathol 2013 1.09
104 Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice. Proc Natl Acad Sci U S A 2012 1.07
105 Distinct single amino acid replacements in the control of virulence regulator protein differentially impact streptococcal pathogenesis. PLoS Pathog 2011 1.07
106 Genomic analysis of the emergence of vancomycin-resistant Staphylococcus aureus. MBio 2012 1.06
107 Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis. Mol Microbiol 2008 1.06
108 Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan. J Biol Chem 2008 1.05
109 Characterization of an extracellular virulence factor made by group A Streptococcus with homology to the Listeria monocytogenes internalin family of proteins. Infect Immun 2003 1.05
110 Streptococcus pyogenes and human neutrophils: a paradigm for evasion of innate host defense by bacterial pathogens. Microbes Infect 2004 1.05
111 Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas. Clin Infect Dis 2002 1.04
112 Bacterial genomics in infectious disease and the clinical pathology laboratory. Arch Pathol Lab Med 2012 1.04
113 Polymorphisms in regulator of protease B (RopB) alter disease phenotype and strain virulence of serotype M3 group A Streptococcus. J Infect Dis 2012 1.02
114 Analysis of a novel prophage-encoded group A Streptococcus extracellular phospholipase A(2). J Biol Chem 2004 1.02
115 Lack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in nonhuman primates. Am J Pathol 2010 1.01
116 Giving TB wheels: Public transportation as a risk factor for tuberculosis transmission. Tuberculosis (Edinb) 2011 1.01
117 Lateral gene transfer of streptococcal ICE element RD2 (region of difference 2) encoding secreted proteins. BMC Microbiol 2011 1.00
118 Comprehensive analysis of antibody responses to streptococcal and tissue antigens in patients with acute rheumatic fever. Int Immunol 2008 0.99
119 Molecular genetic analysis of 675 group A streptococcus isolates collected in a carrier study at Lackland Air Force Base, San Antonio, Texas. J Infect Dis 2003 0.98
120 Epidemiology of pediatric tuberculosis using traditional and molecular techniques: Houston, Texas. Pediatrics 2005 0.98
121 Virulence gene expression in vivo. Curr Opin Microbiol 2004 0.97
122 Strategy for rapid identification and antibiotic susceptibility testing of gram-negative bacteria directly recovered from positive blood cultures using the Bruker MALDI Biotyper and the BD Phoenix system. J Clin Microbiol 2012 0.97
123 Identification of srv, a PrfA-like regulator of group A streptococcus that influences virulence. Infect Immun 2004 0.97
124 The heterogeneity of endemic community pediatric group a streptococcal pharyngeal isolates and their relationship to invasive isolates. J Infect Dis 2002 0.97
125 Identification of point mutations in clinical Staphylococcus aureus strains that produce small-colony variants auxotrophic for menadione. Infect Immun 2014 0.97
126 Crystal structure of group A streptococcus Mac-1: insight into dimer-mediated specificity for recognition of human IgG. Structure 2006 0.96
127 Drug-resistant tuberculosis: a disease of target populations in Houston, Texas. J Infect 2005 0.96
128 emm typing of invasive T28 group A streptococci, 1995-2004, Finland. J Med Microbiol 2006 0.96
129 An amino-terminal signal peptide of Vfr protein negatively influences RopB-dependent SpeB expression and attenuates virulence in Streptococcus pyogenes. Mol Microbiol 2011 0.95
130 Interactome analysis of longitudinal pharyngeal infection of cynomolgus macaques by group A Streptococcus. Proc Natl Acad Sci U S A 2010 0.95
131 The effect of mannose binding lectin gene polymorphisms on susceptibility to tuberculosis in different ethnic groups. Scand J Infect Dis 2004 0.94
132 Remodeling of the Streptococcus agalactiae transcriptome in response to growth temperature. PLoS One 2008 0.94
133 Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect Immun 2002 0.94
134 Transcriptome adaptation of group B Streptococcus to growth in human amniotic fluid. PLoS One 2009 0.94
135 MalE of group A Streptococcus participates in the rapid transport of maltotriose and longer maltodextrins. J Bacteriol 2007 0.93
136 Regulation of polysaccharide utilization contributes to the persistence of group a streptococcus in the oropharynx. Infect Immun 2007 0.91
137 Crystal structure of peroxide stress regulator from Streptococcus pyogenes provides functional insights into the mechanism of oxidative stress sensing. J Biol Chem 2013 0.90
138 Mortality associated with central nervous system tuberculosis. J Infect 2007 0.90
139 Intrahost sequence variation in the streptococcal inhibitor of complement gene in patients with human pharyngitis. J Infect Dis 2003 0.89
140 Severe necrotizing fasciitis in a human immunodeficiency virus-positive patient caused by methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2008 0.89
141 Characterization of the immune response to collagen-like proteins Scl1 and Scl2 of serotype M1 and M28 group A Streptococcus. FEMS Microbiol Lett 2007 0.88
142 A non-human primate model of acute group a Streptococcus pharyngitis. Methods Mol Biol 2008 0.88
143 Natural variation in the promoter of the gene encoding the Mga regulator alters host-pathogen interactions in group a Streptococcus carrier strains. Infect Immun 2013 0.88
144 Spread of virulent group A Streptococcus type emm59 from Montana to Wyoming, USA. Emerg Infect Dis 2014 0.88
145 Axis of coinfection evil. J Infect Dis 2010 0.87
146 Stable isotope labeling of a Group A Streptococcus virulence factor using a chemically defined growth medium. Protein Expr Purif 2003 0.87
147 Is alcohol use associated with cavitary disease in tuberculosis? Alcohol Clin Exp Res 2007 0.87
148 Adaptation of group A Streptococcus to human amniotic fluid. PLoS One 2010 0.87
149 Histidine and aspartic acid residues important for immunoglobulin G endopeptidase activity of the group A Streptococcus opsonophagocytosis-inhibiting Mac protein. Infect Immun 2003 0.86
150 Molecular characterization of an invasive phenotype of group A Streptococcus arising during human infection using whole genome sequencing of multiple isolates from the same patient. J Infect Dis 2013 0.85
151 Inactivation of the group A Streptococcus regulator srv results in chromosome wide reduction of transcript levels, and changes in extracellular levels of Sic and SpeB. FEMS Immunol Med Microbiol 2006 0.85
152 Including the third dimension: a spatial analysis of TB cases in Houston Harris County. Tuberculosis (Edinb) 2011 0.84
153 How to approach genome wars in sepsis? Crit Care 2011 0.83
154 Contribution of AmyA, an extracellular alpha-glucan degrading enzyme, to group A streptococcal host-pathogen interaction. Mol Microbiol 2009 0.83
155 No evidence for association between the polymorphism in the 3' untranslated region of interleukin-12B and human susceptibility to tuberculosis. J Infect Dis 2003 0.83
156 Interferon-gamma receptor 1 promoter polymorphisms: population distribution and functional implications. Clin Immunol 2004 0.83
157 Relating the size of molecularly defined clusters of tuberculosis to the duration of symptoms. Clin Infect Dis 2003 0.83
158 TCA cycle inactivation in Staphylococcus aureus alters nitric oxide production in RAW 264.7 cells. Mol Cell Biochem 2011 0.83
159 Improving positive blood culture removal time significantly decreases total processing time. Arch Pathol Lab Med 2014 0.82
160 Evolution of diversity in epidemics revealed by analysis of the human bacterial pathogen group A Streptococcus. Epidemics 2011 0.82
161 Vaccine protection against Bacillus cereus-mediated respiratory anthrax-like disease in mice. Infect Immun 2013 0.81
162 Lower respiratory tract infection in cynomolgus macaques (Macaca fascicularis) infected with group A Streptococcus. Microb Pathog 2010 0.80
163 Niche-specific contribution to streptococcal virulence of a MalR-regulated carbohydrate binding protein. Mol Microbiol 2011 0.80
164 Differential virulence gene expression of group A Streptococcus serotype M3 in response to co-culture with Moraxella catarrhalis. PLoS One 2013 0.79
165 Spontaneous bacterial pericarditis with tamponade due to Ureaplasma spp. J Clin Microbiol 2009 0.78
166 Diagnostic associations between pleural and pulmonary tuberculosis. J Infect 2006 0.78
167 Analysis of growth-phase regulated genes in Streptococcus agalactiae by global transcript profiling. BMC Microbiol 2009 0.78
168 Identification of an unusual pattern of global gene expression in group B Streptococcus grown in human blood. PLoS One 2009 0.77
169 Number of negative acid-fast smears needed to adequately assess infectivity of patients with pulmonary tuberculosis. Chest 2005 0.77
170 The next chapter in reverse vaccinology. Nat Biotechnol 2006 0.77
171 Comparative whole genome sequencing of community-associated methicillin-resistant Staphylococcus aureus sequence type 8 from primary care clinics in a Texas community. Pharmacotherapy 2015 0.77
172 Counting the homeless: a previously incalculable tuberculosis risk and its social determinants. Am J Public Health 2013 0.76
173 Pediatric tuberculosis: the litmus test for tuberculosis control. Pediatr Infect Dis J 2012 0.76
174 Third-track pathology: in unambiguous support of the Banbury Conference report. Arch Pathol Lab Med 2011 0.75